{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:38:48Z","timestamp":1759937928636,"version":"3.44.0"},"reference-count":15,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"accepted":{"date-parts":[[2019,3,21]]},"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1136\/dtb.2019.000011","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:45:25Z","timestamp":1559123125000},"page":"89-92","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["\u25bcOspemifene for vulvar and vaginal atrophy"],"prefix":"10.1136","volume":"57","member":"239","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"2025082723505755000_57.6.89.1","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0413"},{"key":"2025082723505755000_57.6.89.2","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0b013e3182a122c2"},{"key":"2025082723505755000_57.6.89.3","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2010.522875"},{"key":"2025082723505755000_57.6.89.4","unstructured":"National Institute for Health and Care Excellence . Menopause: diagnosis and management (NG23) [online]. 2015. Available: https:\/\/www.nice.org.uk\/guidance\/ng23\/ [Accessed 20 March 2019]."},{"key":"2025082723505755000_57.6.89.5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2236"},{"key":"2025082723505755000_57.6.89.6","unstructured":"Senshio 60 mg film-coated tablets . Summary of product characteristics. EU: Shionogi Limited, July 2018."},{"key":"2025082723505755000_57.6.89.7","unstructured":"European Medicines Agency . Assessment Report Senshio [online]. 2014. Available: https:\/\/www.ema.europa.eu\/documents\/assessment-report\/senshio-epar-public-assessment-report_en.pdf [Accessed 20 March 2019]."},{"key":"2025082723505755000_57.6.89.8","unstructured":"Food and Drug Administration . Estrogen and estrogen\/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms \u2014 recommendations for clinical evaluation [online]. 2003. Available: https:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm071643.pdf [Accessed 20 March 2019]."},{"key":"2025082723505755000_57.6.89.9","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e3181c1ac01"},{"key":"2025082723505755000_57.6.89.10","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e318279ba64"},{"key":"2025082723505755000_57.6.89.11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.maturitas.2014.02.015","article-title":"Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial","volume":"78","author":"Portman","year":"2014","journal-title":"Maturitas"},{"key":"2025082723505755000_57.6.89.12","unstructured":"US National Library of Medicine . Efficacy and safety of ospemifene in the treatment of moderate to severe vaginal dryness and vaginal pain associated with sexual activity (NCT 00729469) [online]. 2018. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00729469 [Accessed 20 March 2019]."},{"key":"2025082723505755000_57.6.89.13","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2013.834493"},{"key":"2025082723505755000_57.6.89.14","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e318182f84b"},{"key":"2025082723505755000_57.6.89.15","unstructured":"European Medicines Agency . Summary of the risk management plan (RMP) for Senshio (ospemifene) [online]. 2014. Available: https:\/\/www.ema.europa.eu\/documents\/rmp-summary\/senshio-epar-risk-management-plan-summary_en.pdf [Accessed 20 March 2019]."}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2019.000011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:51:09Z","timestamp":1756363869000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2019.000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,5,29]]},"published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1136\/dtb.2019.000011"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2019.000011","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2019,5,29]]}}}